184 related articles for article (PubMed ID: 18675843)
1. The expression of locomotor sensitization to apomorphine is dependent on time interval between injection and testing.
Braga PQ; Galvanho JP; Bloise E; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2009 Jan; 91(3):278-82. PubMed ID: 18675843
[TBL] [Abstract][Full Text] [Related]
2. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
3. Low dose apomorphine induces context-specific sensitization of hypolocomotion without conditioning: support for a new state dependent retrieval hypothesis of drug conditioning and sensitization.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2009 Aug; 93(2):128-33. PubMed ID: 19414026
[TBL] [Abstract][Full Text] [Related]
4. Behavioral sensitization produced by a single administration of apomorphine: implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization.
Bloise E; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2007 Mar; 86(3):449-57. PubMed ID: 17289130
[TBL] [Abstract][Full Text] [Related]
5. Stimulus gated cocaine sensitization: interoceptive drug cue control of cocaine locomotor sensitization.
Carey RJ; DePalma G; Damianopoulos E; Shanahan A
Pharmacol Biochem Behav; 2005 Oct; 82(2):353-60. PubMed ID: 16216323
[TBL] [Abstract][Full Text] [Related]
6. Behavioral sensitization to dopaminergic inhibitory and stimulatory effects induced by low vs. high dose apomorphine treatments: an unconventional dose and response reversal sensitization challenge test reveals sensitization mechanisms.
Braga PQ; Dias FR; Carey RJ; Carrera MP
Behav Brain Res; 2009 Dec; 204(1):169-74. PubMed ID: 19520118
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine locomotor sensitization can be potentiated by environmental change: evidence for a non-Pavlovian associative behavioral contrast factor in sensitization expression.
Coelho GC; Galvanho JP; Carey RJ; Carrera MP
Behav Brain Res; 2011 Jun; 220(1):146-51. PubMed ID: 21295617
[TBL] [Abstract][Full Text] [Related]
8. Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D(2) receptor activation is critical but not the expression of the unconditioned response.
Dias FR; Carey RJ; Carrera MP
Brain Res; 2006 Apr; 1083(1):85-95. PubMed ID: 16530737
[TBL] [Abstract][Full Text] [Related]
9. Stimulus and response factors affecting the development of behavioral sensitization to apomorphine.
Mattingly BA; Koch C; Osborne FH; Gotsick JE
Psychopharmacology (Berl); 1997 Mar; 130(2):109-16. PubMed ID: 9106907
[TBL] [Abstract][Full Text] [Related]
10. Drug memory substitution during re-consolidation: a single inhibitory autoreceptor apomorphine treatment given during psychostimulant memory re-consolidation replaces psychostimulant conditioning with conditioned inhibition and reverses psychostimulant sensitization.
de Mello Bastos JM; Dias FR; Alves VH; Carey RJ; Carrera MP
Behav Brain Res; 2014 Mar; 260():139-47. PubMed ID: 24239895
[TBL] [Abstract][Full Text] [Related]
11. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
Morgenstern R; Fink H
Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255
[TBL] [Abstract][Full Text] [Related]
12. Drug conditioning induced by intrastriatal apomorphine administration.
Pinheiro Carrera M; Brunhara FC; Schwarting RK; Tomaz C
Brain Res; 1998 Apr; 790(1-2):60-6. PubMed ID: 9593824
[TBL] [Abstract][Full Text] [Related]
13. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
Hoffmann LC; Schütte SR; Koch M; Schwabe K
Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
[TBL] [Abstract][Full Text] [Related]
15. Reversal of apomorphine locomotor sensitization by a single post-conditioning trial treatment with a low autoreceptor dose of apomorphine: a memory re-consolidation approach.
Carrera MP; Carey RJ; Dias FR; de Matos LW
Pharmacol Biochem Behav; 2011 Jul; 99(1):29-34. PubMed ID: 21447355
[TBL] [Abstract][Full Text] [Related]
16. Increase in medial frontal cortex ERK activation following the induction of apomorphine sensitization.
Sanguedo FV; Dias FR; Bloise E; Cespedes IC; Giraldi-Guimarães A; Samuels RI; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2014 Mar; 118():60-8. PubMed ID: 24380761
[TBL] [Abstract][Full Text] [Related]
17. [Diphasic action of apomorphine on motility in the rat. II. Time aspects of the effect of a single dose].
Vaccheri A; Gandolfi O; Dall'Olio R; Montanaro N
Boll Soc Ital Biol Sper; 1981 Feb; 57(4):381-6. PubMed ID: 7236418
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine conditioning and sensitization: the paired/unpaired treatment order as a new major determinant of drug conditioned and sensitization effects.
de Matos LW; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2010 Sep; 96(3):317-24. PubMed ID: 20670918
[TBL] [Abstract][Full Text] [Related]
19. Repeated pre-trial and post-trial low and high dose apomorphine treatments induce comparable inhibitory/excitatory sensitization and conditioned drug effects.
Santos BG; Carey RJ; Carrera MP
Pharmacol Biochem Behav; 2018 Dec; 175():108-115. PubMed ID: 30267795
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic cocaine behavioral effects in novel versus familiar environments: open-field familiarity differentiates cocaine locomotor stimulant effects from cocaine emotional behavioral effects.
Carey RJ; DePalma G; Damianopoulos E
Behav Brain Res; 2005 Mar; 158(2):321-30. PubMed ID: 15698899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
